ANGO vs BBY · rev $292.5M vs P/E 14, rev $41.53B
AngioDynamics Inc (ANGO) versus Best Buy Co. Inc (BBY) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BBY revenue for 2025-02-01 was $41.53B. Net income was $927.0M. Revenue was down 4.4% from 2024-02-03 to 2025-02-01. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
ANGO currently screens at market cap $378.5M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Not investment advice. Open the ANGO and BBY stock pages for the full models.
Not investment advice.